Aclaris Therapeutics

Aclaris Therapeutics

Aclaris Therapeutics is a company developing treatments for dermatology and immunology.

All edits by  Liron Shapira 

Edits on 30 Apr 2019
Liron Shapira
Liron Shapira approved a suggestion from Golden's AI on 30 Apr 2019 9:13 pm
Edits made to:
Article (+8/-8 characters)


Aclaris has two commercialized products in its portfolio, Eskata and Rhofade. Eskata is topical treatment for SKs (seborrheic keratoses). SKs are harmless spots that pop up as a person ages. Rhofade on the other hand, is a topical treatment for persistent facial erythema associated with rosacea in adults. Rhofade was originally developed by AllerganAllergan, which Aclaris then acquired the worldwide rights to.

No more activity to show.